Top

Administration and Policy in Mental Health and Mental Health Services Research

Published in:

01-07-2016 | Original Article

An Economic Evaluation of a Weight Loss Intervention Program for People with Serious Mental Illnesses Taking Antipsychotic Medications

Authors: Richard T. Meenan, Scott P. Stumbo, Micah T. Yarborough, Michael C. Leo, Bobbi Jo H. Yarborough, Carla A. Green

Published in: Administration and Policy in Mental Health and Mental Health Services Research | Issue 4/2016

Abstract

Individuals with serious mental illnesses suffer from obesity and cardiometabolic diseases at high rates, and antipsychotic medications exacerbate these conditions. While studies have shown weight loss and lifestyle interventions can be effective in this population, few have assessed intervention cost-effectiveness. We present results from a 12-month randomized controlled trial that reduced weight, fasting glucose, and medical hospitalizations in intervention participants. Costs per participant ranged from $4365 to $5687. Costs to reduce weight by one kilogram ranged from $1623 to $2114; costs to reduce fasting glucose by 1 mg/dL ranged from $467 to $608. Medical hospitalization costs were reduced by $137,500.

Borushek, A. (2012). The calorie king, calorie, fat, and carbohydrate counter 2013. Costa Mesa: Family Health Publications.

Briggs, A. H. (2000). Handling uncertainty in cost-effectiveness models. Pharmacoeconomics, 17(5), 479–500.CrossRefPubMed

Chaggar, P. S., Shaw, S. M., & Williams, S. G. (2011). Effect of antipsychotic medications on glucose and lipid levels. Journal of Clinical Pharmacology, 51(5), 631–638.CrossRefPubMed

Colton, C. W., & Manderscheid, R. W. (2006). Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease, 3(2), A42.PubMedPubMedCentral

Daumit, G. L., Dickerson, F. B., Wang, N. Y., Dalcin, A., Jerome, G. J., Anderson, C. A., & Appel, L. J. (2013). a behavioral weight-loss intervention in persons with serious mental illness. The New England Journal of Medicine, 368(17), 1594–1602.CrossRefPubMedPubMedCentral

Diabetes Prevention Program Research Group. (2003). Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care, 26(9), 2518–2523.CrossRef

Diabetes Prevention Program Research Group. (2012). The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care, 35(4), 723–730. doi:10.2337/dc11-1468.CrossRef

Druss, B. G., Zhao, L., Von, E. S., Morrato, E. H., & Marcus, S. C. (2011). Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Medical Care, 49(6), 599–604.CrossRefPubMed

Espeland, M. A., Glick, H. A., Bertoni, A., Brancati, F. L., Bray, G. A., Clark, J. M., & Zhang, P. (2014). Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care, 37(9), 2548–2556.CrossRefPubMedPubMedCentral

EuroQol Group. (2014). EQ-5D Website. from www.euroqol.org/home.html.

Finkelstein, E. A., & Kruger, E. (2014). Meta- and cost-effectiveness analysis of commercial weight loss strategies. Obesity, 22(9), 1942–1951. doi:10.1002/oby.20824.CrossRefPubMed

Forster, M., Veerman, J. L., Barendregt, J. J., & Vos, T. (2011). Cost-effectiveness of diet and exercise interventions to reduce overweight and obesity. International Journal of Obesity (2005), 35(8), 1071–1078. doi:10.1038/ijo.2010.246.CrossRef

Funk, K. L., Elmer, P. J., Stevens, V. J., Harsha, D. W., Craddick, S. R., Lin, P. H., & Appel, L. J. (2006). PREMIER–A trial of lifestyle interventions for blood pressure control: Intervention design and rationale. Health Promotion Practice, 9(3), 271–280.CrossRefPubMed

Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.

Green, C. A., Yarborough, B. J., Leo, M. C., Yarborough, M. T., Stumbo, S. P., Janoff, S. L., & Stevens, V. J. (2015). The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: A randomized trial. American Journal of Psychiatry, 172(1), 71–81. doi:10.1176/appi.ajp.2014.14020173.CrossRefPubMedPubMedCentral

Inflation.eu. (2015). Historic harmonised inflation Belgium—HICP inflation. Retrieved June 2, 2015, from www.inflation.eu/inflation-rates/belgium/historic-inflation/hicp-inflation-belgium.aspx.

Jensen, M. D., Ryan, D. H., Apovian, C. M., Loria, C. M., Ard, J. D., Millen, B. E., et al. (2014). 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the obesity society. Journal of the American College of Cardiology, 63(25 Pt B), 2985–3023.CrossRefPubMed

Kilbourne, A. M., Morden, N. E., Austin, K., Ilgen, M., McCarthy, J. F., Dalack, G., & Blow, F. C. (2009). Excess heart-disease-related mortality in a national study of patients with mental disorders: Identifying modifiable risk factors. General Hospital Psychiatry, 31(6), 555–563.CrossRefPubMedPubMedCentral

Lehnert, T., Sonntag, D., Konnopka, A., Riedel-Heller, S., & Konig, H. H. (2012). The long-term cost-effectiveness of obesity prevention interventions: systematic literature review. Obesity Reviews, 13(6), 537–553.CrossRefPubMed

Malhotra, A. K., Correll, C. U., Chowdhury, N. I., Muller, D. J., Gregersen, P. K., Lee, A. T., et al. (2012). Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Archives of General Psychiatry, 69(9), 904–912.CrossRefPubMedPubMedCentral

Manning, W. G., Fryback, D. F., & Weinstein, M. C. (1996). Reflecting uncertainty in cost-effectiveness analysis. In M. R. Gold, J. E. Siegel, L. B. Russell, & W. C. Weinstein (Eds.), Cost effectiveness in health and medicine. New York: Oxford University Press. (Reprinted from: IN FILE).

Meenan, R. T., Stevens, V. J., Funk, K., Bauck, A., Jerome, G. J., Lien, L. F., & Svetkey, L. P. (2009). Development and implementation cost analysis of telephone- and Internet-based interventions for the maintenance of weight loss. International Journal of Technology Assessment in Health Care, 25(3), 400–410. doi:10.1017/S0266462309990018.CrossRefPubMedPubMedCentral

Meenan, R. T., Stevens, V. J., Hornbrook, M. C., LaChance, P. A., Hollis, J. F., Glasgow, R. E., & Lichtenstein, E. (1998). Cost-effectiveness of a hospital-based smoking-cessation interention. Medical Care, 36(5), 670–678.CrossRefPubMed

Meenan, R. T., Vogt, T. M., Williams, A. E., Stevens, V. J., Albright, C. L., & Nigg, C. (2010). Economic evaluation of a worksite obesity prevention and intervention trial among hotel workers in Hawaii. Journal of Occupational and Environmental Medicine, 52(Suppl 1), S8–13. doi:10.1097/JOM.0b013e3181c81af9.CrossRefPubMedPubMedCentral

National Heart, Lung, and Blood Institute. (2006). Your guide to lowering your blood pressure with DASH, NIH Publication No. 06-4082. http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf.

Newcomer, J. W. (2007). Metabolic considerations in the use of antipsychotic medications: A review of recent evidence. The Journal of Clinical Psychiatry, 68(Suppl 1), 20–27.PubMed

Pfuntner, A., Wier, L. M., & Steiner, C. (2013). Costs for Hospital Stays in the United States, 2011: Statistical Brief #168 Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality.

Ritzwoller, D. P., Glasgow, R. E., Sukhanova, A. Y., Bennett, G. G., Warner, E. T., Greaney, M. L., et al. (2013). Economic analyses of the Be Fit Be Well Program: A weight loss program for community health centers. Journal of General Internal Medicine, 28(12), 1581–1588.CrossRefPubMedPubMedCentral

Ritzwoller, D. P., Sukhanova, A., Gaglio, B., & Glasgow, R. E. (2009). Costing behavioral interventions: A practical guide to enhance translation. Annals of Behavioral Medicine, 37(2), 218–227.CrossRefPubMed

Ritzwoller, D. P., Sukhanova, A. S., Glasgow, R. E., Strycker, L. A., King, D. K., Gaglio, B., & Toobert, D. J. (2011). Intervention costs and cost-effectiveness for a multiple-risk-factor diabetes self-management trial for Latinas: Economic analysis of Viva Bien! Translational Behavioral Medicine, 1(3), 427–435.CrossRefPubMedPubMedCentral

Roux, L., Kuntz, K. M., Donaldson, C., & Goldie, S. J. (2006). Economic evaluation of weight loss interventions in overweight and obese women. Obesity (Silver Spring), 14(6), 1093–1106. doi:10.1038/oby.2006.125.CrossRef

Stumbo, S. P., Yarborough, B. J., Yarborough, M. T., Janoff, S. L., Lewinsohn, M., & Green, C. A. (2015). Costs of implementing a behavioral weight-loss and lifestyle-change program for individuals with serious mental illnesses in community settings. Translational Behavioral Medicine,. doi:10.1007/s13142-015-0322-3.PubMedPubMedCentral

Svetkey, L. P., Harsha, D. W., Vollmer, W. M., Stevens, V. J., Obarzanek, E., Elmer, P. J., & Appel, L. J. (2003). Premier: A clinical trial of comprehensive lifestyle modification for blood pressure control: Rationale, design and baseline characteristics. Annals of Epidemiology, 13(6), 462–471.CrossRefPubMed

Toobert, D. J., Strycker, L. A., Barrera, M, Jr, Osuna, D., King, D. K., & Glasgow, R. E. (2011). Outcomes from a multiple risk factor diabetes self-management trial for Latinas: inverted exclamation markViva Bien! Annals of Behavioral Medicine, 41(3), 310–323. doi:10.1007/s12160-010-9256-7.CrossRefPubMedPubMedCentral

Tsai, A. G., Wadden, T. A., Volger, S., Sarwer, D. B., Vetter, M., Kumanyika, S., et al. (2013). Cost-effectiveness of a primary care intervention to treat obesity. International Journal of Obesity, 37(Suppl 1), 31–37. doi:10.1038/ijo.2013.94.CrossRef

Tunis, S. L., Croghan, T. W., Heilman, D. K., Johnstone, B. M., & Obenchain, R. L. (1999). Reliability, validity, and application of the medical outcomes study 36- item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol. Medical Care, 37(7), 678–691.CrossRefPubMed

United States Department of Labor Bureau of Labor Statistics. (2007). CPI Detailed Report; Data for December 2007. Table 28. Historical Consumer Price Index for Urban Wage Earners and Clerical Workers (CPI-W). U.S. city average, by commodity and service group and detailed expenditure categories. Retrieved June 2, 2015, from www.bls.gov/cpi/cpid0712.pdf.

United States Department of Labor Bureau of Labor Statistics. (2014). Occupational employment statistics: May 2013 national occupational employment and wage estimates. http://www.bls.gov/oes/current/oes_nat.htm#21-0000.

United States Department of Labor Bureau of Labor Statistics. (2015). CPI Detailed Report; Data for April 2015. Table 28. Historical consumer price index for urban wage earners and clerical workers (CPI-W). U.S. city average, by commodity and service group and detailed expenditure categories. Retrieved June 2, 2015, from www.bls.gov/cpi/cpid1504.pdf.

Verhaeghe, N., Clays, E., Vereecken, C., De Maeseneer, J., Maes, L., Van Heeringen, C., et al. (2013). Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial. BMC Public Health, 13, 657. doi:10.1186/1471-2458-13-657.CrossRefPubMedPubMedCentral

Verhaeghe, N., De Smedt, D., De Maeseneer, J., Maes, L., Van Heeringen, C., & Annemans, L. (2014). Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care. BMC Public Health, 14, 856. doi:10.1186/1471-2458-14-856.CrossRefPubMedPubMedCentral

Ware, J. E., Kosinski, M., & Keller, S. D. (1995). SF-12: How to score the SF-12 physical and mental health summary scales. Boston: The Health Institute, New England Medical Center.

Yarborough, B. J., Janoff, S. L., Stevens, V. J., Kohler, D., & Green, C. A. (2011). Delivering a lifestyle and weight loss intervention to individuals in real-world mental health settings: Lessons and opportunities. Translational Behavioral Medicine, 1(3), 406–415.CrossRefPubMedPubMedCentral

Yarborough, B. J., Leo, M. C., Stumbo, S., Perrin, N. A., & Green, C. A. (2013). STRIDE: a randomized trial of a lifestyle intervention to promote weight loss among individuals taking antipsychotic medications. BMC Psychiatry, 13(1), 238.CrossRefPubMedPubMedCentral

Title: An Economic Evaluation of a Weight Loss Intervention Program for People with Serious Mental Illnesses Taking Antipsychotic Medications
Authors: Richard T. Meenan
Scott P. Stumbo
Micah T. Yarborough
Michael C. Leo
Bobbi Jo H. Yarborough
Carla A. Green
Publication date: 01-07-2016
Publisher: Springer US
Published in: Administration and Policy in Mental Health and Mental Health Services Research / Issue 4/2016
Print ISSN: 0894-587X
Electronic ISSN: 1573-3289
DOI: https://doi.org/10.1007/s10488-015-0669-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

An Economic Evaluation of a Weight Loss Intervention Program for People with Serious Mental Illnesses Taking Antipsychotic Medications

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2016

The Healthy Immigrant Effect on Mental Health: Determinants and Implications for Mental Health Policy in Spain

Does the Hospital Predict Readmission? A Multi-level Survival Analysis Approach

Projected Spending on Psychotropic Medications 2013–2020

Treatment Efficacy of Integrative Family and Systems Treatment (I-FAST) With and Without Consultation: The Role of Model Training in the Sustainability of Evidence-Based Family Treatments

A Comparison of Benefit Limits in Mental Health

Online Information Searches and Help Seeking for Mental Health Problems in Urban China